Literature DB >> 26557891

Crohn's disease: a clinical update.

Francis Ha1, Hanan Khalil2.   

Abstract

Crohn's disease is increasing in prevalence worldwide. It arises from a complex interplay between both genetic predisposition and environmental influence. A search of databases and clinical practice guidelines was performed to provide the most up-to-date evidence-based approach for diagnosing and managing patients with Crohn's disease. No single gold standard investigation exists. Whilst full ileocolonoscopy with biopsies remains the mainstay for diagnosis, other less invasive imaging modalities are being actively considered in the workup, as well as the use of serological markers. Management should incorporate dietary and lifestyle modifications where necessary, the use of medications in induction and remission of disease, and consideration of surgical intervention where medical therapy has failed.

Entities:  

Keywords:  Crohn’s disease; colorectal cancer; diagnosis; inflammatory bowel disease; investigations; management; risk factors

Year:  2015        PMID: 26557891      PMCID: PMC4622286          DOI: 10.1177/1756283X15592585

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  73 in total

1.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

2.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

3.  Role of genetic and environmental factors in British twins with inflammatory bowel disease.

Authors:  Siew C Ng; Susannah Woodrow; Nisha Patel; Javaid Subhani; Marcus Harbord
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

Review 4.  Introducing vedolizumab to clinical practice: who, when, and how?

Authors:  R V Bryant; W J Sandborn; S P L Travis
Journal:  J Crohns Colitis       Date:  2015-02-16       Impact factor: 9.071

5.  Advantages of laparoscopic resection for ileocecal Crohn's disease.

Authors:  Hans-Joachim Duepree; Anthony J Senagore; Conor P Delaney; Karen M Brady; Victor W Fazio
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

6.  A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease.

Authors:  Mark A Feeney; Frank Murphy; Andrew J Clegg; Timothy M Trebble; Nicholas M Sharer; Jonathon A Snook
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-05       Impact factor: 2.566

Review 7.  Serologic markers in inflammatory bowel disease.

Authors:  Xavier Bossuyt
Journal:  Clin Chem       Date:  2005-12-08       Impact factor: 8.327

Review 8.  Capsule endoscopy.

Authors:  Miguel Muñoz-Navas
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

Review 9.  Capsule endoscopy: past, present, and future.

Authors:  Tetsuya Nakamura; Akira Terano
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

10.  Laparoscopic surgery for Crohn's disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery.

Authors:  Sunil V Patel; Sanjay V B Patel; Sreeram V Ramagopalan; Michael C Ott
Journal:  BMC Surg       Date:  2013-05-24       Impact factor: 2.102

View more
  13 in total

1.  Alterations in Blood Plasma Metabolome of Patients with Lesniowski-Crohn's Disease Shortly after Surgical Treatment-Pilot Study.

Authors:  Jakub Idkowiak; Grażyna Kubiak-Tomaszewska; Paulina Gątarek; Łukasz Marczak; Joanna Kałużna-Czaplińska; Wiesław Tarnowski; Mariusz Uryszek; Barbara Bobrowska-Korczak
Journal:  Metabolites       Date:  2022-06-08

Review 2.  Stem cell transplantation for induction of remission in medically refractory Crohn's disease.

Authors:  Sarah El-Nakeep; Ahmed Shawky; Sara F Abbas; Osama Abdel Latif
Journal:  Cochrane Database Syst Rev       Date:  2022-05-13

3.  Awareness and cognition of illness in Saudi Arabian patients with Crohn's disease.

Authors:  Mahmoud Mosli; Asala Saeedi; Majed Alnefaie; Noor Bawahab; Lujain Abdo; Seigha Shobai; Majid Alsahafi; Omar Saadah
Journal:  Saudi J Gastroenterol       Date:  2021 Mar-Apr       Impact factor: 2.485

Review 4.  Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.

Authors:  Moses M Kasembeli; Uddalak Bharadwaj; Prema Robinson; David J Tweardy
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923

5.  Recurring Lower Abdominal Pain and Fever as Initial Presentation of Adult Onset Still's Disease in the Absence of Arthralgia and Other System Involvement.

Authors:  Abuajela Sreh; Nithyananda Rajaiah; Mohammad Saim
Journal:  Eur J Case Rep Intern Med       Date:  2017-05-09

6.  Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.

Authors:  Yue Li; Baili Chen; Xiang Gao; Naizhong Hu; Meifang Huang; Zhihua Ran; Zhanju Liu; Jie Zhong; Duowu Zou; Xiaoping Wu; Jianlin Ren; Jianqiu Sheng; Ping Zheng; Huahong Wang; Minhu Chen; Junrong Chen; Peng Xi; Jiajia Lu; Malcolm Handel; Yanfang Liu; Hua Fan; Jiaming Qian
Journal:  BMC Gastroenterol       Date:  2019-08-16       Impact factor: 3.067

Review 7.  Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease.

Authors:  Bahez Gareb; Antonius T Otten; Henderik W Frijlink; Gerard Dijkstra; Jos G W Kosterink
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

8.  Low FODMAP diet in Egyptian patients with Crohn's disease in remission phase with functional gastrointestinal symptoms.

Authors:  Maha H Elhusseiny; Ali K Amine; Osama E Salem; Dalia I Tayel; Eman A Elsayed
Journal:  JGH Open       Date:  2018-02-05

Review 9.  Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies.

Authors:  Amandip Kaur; Paraskevi Goggolidou
Journal:  J Inflamm (Lond)       Date:  2020-04-21       Impact factor: 4.981

Review 10.  Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.

Authors:  Xiaomo Wu; Ju Jiang; Zhongkai Gu; Jinyan Zhang; Yang Chen; Xiaolong Liu
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.